MGO One Seven’s Pfizer PFE Stock Holding History

MGO One Seven’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5	Closed	-$1K	–	1869
2017 Q4	$1K	Buy	+5	New	+$170	﹤0.01%	1671

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MGO One Seven's PFE Position: Q2 2026 in Review

MGO One Seven reduced its Pfizer (PFE) stake by 4.5% in Q2 2026, selling an estimated $172K and leaving 138,195 shares worth $3.33M. The position accounts for 0.06% of the portfolio, ranked #357.

MGO One Seven first reported a position in PFE in Q4 2017 and has held it in 34 quarters since. The position peaked at $6.14M in Q3 2022. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

MGO One Seven held 138,195 shares of Pfizer worth $3.33M as of Q2 2026.
MGO One Seven sold 6,586 Pfizer shares in Q2 2026, an estimated $172K.
Pfizer made up 0.06% of MGO One Seven's portfolio in Q2 2026, its #357 holding.
MGO One Seven first reported a position in Pfizer in Q4 2017 and has held it in 34 quarters since.
MGO One Seven's Pfizer position peaked at $6.14M in Q3 2022.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.